Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

HealthDay News — Subthalamic deep brain stimulation (DBS) is an effective long-term therapy for Parkinson disease (PD), according to a study published online September 15 in JAMA Neurology.

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has begun across the UK.

Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's ...

The latest update is out from PharmaTher Holdings Ltd ( (TSE:PHRM) ).

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing Toronto, Ontario–(Newsfile Corp.

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...